[vous aimeriez bien lire cet article en français n'est-ce pas!!! il doit
être bien intéressant... soit vous vous débrouillez au mieux avec votre
dictionnaire, soit vous vous dites que vous pourriez aider les modérateurs
de e-med et que vous voulez bien nous donner un coup de main de temps en
temps dans les traductions... merci d'avance de vous signaler !
Nous avions parlé plusieurs fois sur e-med de cette affaire, vous retrouverez les anciens messages dans les archives de e-med
Carinne Bruneton c.bruneton@remed.org]
http://allafrica.com/stories/201001260683.html
Pfizer Compensates Trovan Victims With N26 Million Each
Joe Nwankwo
Daily Independent (Lagos)
25 January 2010
Abuja, PFIZER has agreed to pay N26 million to each family of the
victims of its Trovan vaccine trials in Kano in 2006, provided there is
proof of death or permanent incapacitation.
About 200 people took part in the trials which resulted in the death of
some patients and the permanent incapacitation of others.
The Meningitis Trust Fund (MTF), a body set up to pay the compensation
on behalf of Pfizer, said it has received over 600 applications from
those who claimed they participated in the tests and want to be compensated=
.
This was disclosed on Monday at the hand over of the report of an out of
court settlement, wherein Pfizer noted that it would deal with
individuals and not associations in paying compensation.
Pfizer counsel, Anthony Idigbe, said they have the files and documents
on medical records and photos which will help determine the gender of
each participant in the test.
The company said: "The records will be very helpful. The tests by
doctors to determine the real patients will be at no cost to those who
have come to make claims. They are free to form an association but we
are not dealing with associations but individuals."
A statement issued in Abuja by Pfizer Media Representative, Emeka
Ozumba, confirmed the handing over on January 19 of files and documents,
including all records of the 200 patients, to MTF Chairman, A. B. Wali.
"The clinical study involved 200 patients with severe cases of
cerebral-spinal meningitis (CSM), 100 of who were treated with
Ceftriaxone, the gold standard drug in use; while others took the
intravenous Trovan," Ozumba added.
"Of these, Ceftriaxone recorded six fatalities while Trovan had five,
making it a total of 11 deaths."
He recounted that the state government initiated court cases, both civil
and criminal, against the test, and after several years and the
intervention of prominent Nigerians, the parties agreed to settle out of
court.
"Under the terms of the settlement, Pfizer and Kano State established a
Healthcare/Meningitis Fund from which the study participants can receive
financial support."
The Fund will also "underwrite several healthcare initiatives chosen by
the Kano State Government that benefit the people of Kano State,
totaling $30 million over a period of two years; and reimburse Kano
State for $10 million in legal costs associated with the litigation.
"There is also the Projects Trust Fund which will handle various health
projects to be located in a complex.
"These include diagnostics centre, centre for disease control, curable
diseases centre, microbiology laboratory and staff housing.
"Kano State recently provided land for the projet.